{{cartTotalQuantity}}
Menu diagnostyki molekularnej
Aparatura i oprogramowanie
Rozwiązania firmy Cepheid
Na całym świecie
Gospodarka antybiotykami
Cepheid’s Insights
Webinaria
Informacje o spółce Cepheid
Misja i historia
Poznaj motocykl Cepheid
Dystrybutorzy
Najnowsze informacje
Wydarzenia
Kariera
Nasi liderzy
Support Center
Skontaktuj się z nami
Czas czytania: 3 min
29 czerwca 2026
Czas czytania: 4 min
5 maja 2026
Czas czytania: 6 min
19 lutego 2026
7m Read
6 maja 2025
Whitepaper
Numerous testing and instrumentation options exist for infectious diseases and sexual health. Standardization provides significant benefits: simplification, consistent performance, and streamlining.
In the wake of the global COVID-19 pandemic that required rapid development of tests, healthcare providers—especially at the point of care (POC)—have been purchasing a variety of POC testing solutions, often from numerous vendors, given the supply chain issues during this time. When the burden of high patient volume began to taper off, hospitals and doctors’ offices reassessed their needs and began consolidating the number of testing instruments.
When deciding which to keep and which to decommission, some instruments’ full capabilities and features should be considered.
The demand for more types of tests to be rapid will only increase. Standardized test menus on a vendor’s range of diagnostic instruments for both hospitals and POC can simplify the consolidation process, standardize test accuracy and performance, and simultaneously expand current testing capabilities—all while providing a consistent patient experience.
WIĘCEJ